| Survival: | 9.6 months |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | |
| Country: | United Kingdom |
| City/State/Province: | London |
| Hospital: | Charing Cross Hospital |
| Journal: | Link |
| Date: | 5/2008 |
| Description: |
| Patients: This phase II study involved 63 patients with relapsed malignant pleural mesothelioma. Their median age was 59, ranging from 29 to 77 years old. The majority (93.6%) of patients were men. Treatment: Patients were treated weekly with the chemotherapy drug vinorelbine. Toxicity: Grade 3/4 neutropenia was reported in 55% of patients; other, less common grade 3/4 toxicities were anemia, constipation, neuropathy, and phlebitis. Results: The median overall survival was 9.6 months. Correspondence: Dr. Justin Stebbing |